MarketPeel
Insider Trading Intelligence
RL

Rivervest Venture Fund Iv, L.p.

XLO
10% OWNER · XILIO THERAPEUTICS, INC. · CIK 0001725443
FILING MIX · LIFETIME60%/40%
BUYS
6
SELLS
4
TOTAL VALUE
$7.75M
COMPANIES
2
ACTIVE SINCE
Oct 2020
HOLDINGS NOW
1,070,172
AVG SELL PX
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Rivervest Venture Fund Iv, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+17.75%-0.10%+17.84%+17.84%
14d2+100.00%+32.54%-1.80%+34.34%+34.34%
30d2+100.00%+26.06%+2.94%+23.11%+23.11%
60d2+50.00%+11.35%+4.19%+7.16%+7.16%
90d2+50.00%+4.69%+3.07%+1.63%+1.63%
180d2+0.00%-42.63%+6.90%-49.53%-49.53%
1y2+0.00%-79.94%+7.01%-86.96%-86.96%
2y2+0.00%-90.48%-0.44%-90.04%-90.04%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XLO · 0 shares · as of Oct 26, 2021
0360,361720,7221,081,0831,441,444SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
FLOW · 6 buys / 4 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
359,3241,191,444Oct 26, 2021Oct 26, 2021View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
832,120832,120Oct 26, 2021Oct 26, 2021View →
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
250,000$16.00$4.00M1,441,444Oct 26, 2021Oct 26, 2021View →
XLO
XILIO THERAPEUTICS, INC.
SALE
359,3240Oct 26, 2021Oct 26, 2021View →
XLO
XILIO THERAPEUTICS, INC.
SALE
832,1200Oct 26, 2021Oct 26, 2021View →
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
828,1091,898,281Oct 14, 2020Oct 16, 2020View →
SPRB
SPRUCE BIOSCIENCES, INC.
SALE
7,000,0000Oct 14, 2020Oct 16, 2020View →
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
250,000$15.00$3.75M2,148,281Oct 14, 2020Oct 16, 2020View →
SPRB
SPRUCE BIOSCIENCES, INC.
SALE
5,416,6660Oct 14, 2020Oct 16, 2020View →
SPRB
SPRUCE BIOSCIENCES, INC.
PURCHASE
1,070,1721,070,172Oct 14, 2020Oct 16, 2020View →
Other insiders · XLO
Loading peer insiders…
About this filer
CIK 0001725443
ROLE
10% Owner
PRIMARY
XLO
COMPANIES
2
ACTIVE SINCE
Oct 2020
MARKETPEEL · /INSIDER/0001725443DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback